Frost & Sullivan to Moderate International Conference at MEDICA 2007

Frost & SullivanHosted by the U.S. Government in partnership with Frost & Sullivan and several strategic partners, the International Conference at MEDICA 2007 is expected to see attendance by every international medical device, equipment and diagnostic company. This pioneering event offers the international medical technology community a unique opportunity to tap the expertise and resources needed to be successful on the world's most important medical market - the USA.

Dorman Followwill, Vice President, Health Care, Frost & Sullivan, who will moderate the conference, notes that this event comes at a time when international medical technology firms, facing strong cost containment pressures, slower growth and challenging regulatory environments, are looking to the U.S. as a rewarding market for innovative products.

"Clearly, the U.S. market offers medical device companies several global competitive advantages," says Followwill. "However, it is essential for international firms to implement the correct strategy on local engagement in the highly competitive U.S. market where volatile currency fluctuations, heightened scrutiny on import safety issues, complex reimbursement systems and regional/local market preferences and practices, all demand careful consideration."

Through this conference, participants will be privy to crucial information and insights aimed at helping international medtech companies establish a presence or expand in the United States. Experts from the U.S. Department of Commerce, its U.S. federal state partners, the U.S. Food and Drug Administration, along with leading industry association officials, company heads and prominent legal, financial and business advisors in the health technology sector will make presentations, participate in panel discussions.

Besides in-depth and insightful information, the forum offers attractive networking opportunities. Attendees can profit from personal consultations with expert speakers and U.S. state representatives during breaks, the relaxed networking reception and in follow on meetings.

In short, anyone responsible for a medical company's global success will find invaluable guidance and networking opportunities on November 13th at the Hilton Hotel, Düsseldorf.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...